Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Richard Beasley (Wellington, New Zealand). Rethinking the way we are treating established airway disease: current guidelines need to change . International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma

Member's Comments

No comment yet.

Related content which might interest you: Translating research into practice: how are guidelines implemented? Source: Eur Respir J 2003; 21: 23S-29S Year: 2003 How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years Year: 2021 Rational monitoring of COPD: where do current clinical guidelines stand? Source: Eur Respir J 2007; 29: 1078-1081 Year: 2007 Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008 What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018 The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017 The new WHO air quality guidelines: policy and clinical implications for children with respiratory diseases Source: Virtual Congress 2021 – The environment and climate change effects on lung health across the lifecourse Year: 2021 Do we really need guidelines? Source: Virtual Congress 2020 – Do we really need guidelines? Year: 2020 Maintaining currency and improving utility of COPD guidelines: an achievable goal? Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Laboratory investigations of infection in COPD: current best practice and future possibilities Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008 The concept of control in COPD: a new proposal for optimising therapy Source: Eur Respir J 2014; 44: 1072-1075 Year: 2014 How can we improve asthma management? Source: Annual Congress 2005 - Asthma management - important issues Year: 2005 Towards individualised medicine for airways disease: identifying clinical phenotype groups Source: Eur Respir J 2012; 39: 1033-1034 Year: 2012 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 A new perspective on concepts of asthma severity, control and optimum treatment Source: Eur Respir J 2009; 33: 704-705 Year: 2009 Decision analytic models in COPD/asthma: A critical review of current evidence Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system Year: 2016 When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma? Source: Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021 Year: 2021